treatment Archives - Page 4 of 5

The Authors’ Own Words: Patient Characteristics Associated with Treatment Initiation and Engagement Among Individuals Diagnosed with Alcohol and Other Drug Use Disorders in the Emergency Department and Primary Care Settings

Nov 25, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Patient Characteristics Associated with Treatment Initiation and Engagement Among Individuals Diagnosed with Alcohol and Other Drug Use Disorders in the Emergency Department and Primary Care Settings

Andrea H. Kline-Simon, MS; Scott P. Stumbo, MA; Cynthia I. Campbell, PhD, MPH; Ingrid A. Binswanger, MD, MPH, MS; Constance Weisner, DrPH, MSW; Irina V. Haller, PhD, MS; Rulin C. Hechter, MD, PhD; Brian K. Ahmedani, PhD, LMSW; Gwen T. Lapham, PhD, MPH, MSW; Amy M. Loree, PhD, Stacy A. Sterling, DrPH, MSW; & Bobbi Jo H. Yarborough, PsyD

Substance Abuse Vol. 40, Iss. 3, 2019

“Based on these study findings, it may be beneficial for clinicians in the ED setting to focus extra attention on younger patients and non-White race/ethnicities; while clinicians in primary care settings may need to spend extra time with older patients and those with a medical comorbidity, to encourage treatment initiation among these groups, though there is also still a need for broad screening in both settings. As the ED and primary care settings are often the first line of care for patients struggling with an AOD use disorder, addressing patients’ needs in these settings as they are identified may help them access and engage in treatment.“

The Authors’ Own Words: The Prevalence of HEDIS Initiation and Engagement in Treatment among Patients with Cannabis Use Disorders in Seven U.S. Health Systems

Nov 25, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

The Prevalence of HEDIS Initiation and Engagement in Treatment among Patients with Cannabis Use Disorders in Seven U.S. Health Systems

Constance Weisner, DrPH, MSW; Cynthia I. Campbell, PhD, MPH; Andrea Altschuler, PhD; Bobbi Jo H. Yarborough, PsyD; Gwen T. Lapham, PhD, MPH, MSW; Ingrid A. Binswanger, MD, MPH, MS; Rulin C. Hechter, MD, PhD; Brian K. Ahmedani, PhD, LMSW; Irina V. Haller, PhD, MS; Stacy A. Sterling, DrPH, MSW; Dennis McCarty, PhD; Derek D. Satre, PhD; & Andrea H. Kline-Simon, MS

Substance Abuse Vol. 40, Iss. 3, 2019

“This observational cohort study of 15,202 patients with a cannabis use disorder (CUD) from seven U.S. healthcare systems is the first known study to describe rates of HEDIS-defined alcohol and other drug use disorder (AOD) measures for initiation and engagement in treatment among patients with a newly diagnosed CUD. For these patients, rates of initiation and engagement were low, with considerable variation across index diagnosis setting, AOD comorbidity at index diagnosis, and patient characteristics. Greater adherence to these system-level treatment measures will likely require strong leader and provider partnerships to improve recognition of and linkage to evidence-based treatment for CUD, particularly for those patients with less AOD severity who could still benefit from treatment.“

The Authors’ Own Words: Counselor turnover in substance use disorder treatment research: Observations from one multi-site trial

Nov 20, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Counselor turnover in substance use disorder treatment research: Observations from one multi-site trial

Mary A. Hatch-Maillette, PhD; Robin Harwick, PhD; John S. Baer, PhD; Tatiana Masters, PhD; Kasie Cloud, MSW; Michelle Peavy, PhD; Katharina Wiest, PhD; Lynette Wright, MSW; Blair Beadnell, MSW; & Elizabeth A. Wells, PhD

Substance Abuse Vol. 40, Iss. 2, 2019

“In this paper, we report on counselor workforce-related implementation challenges in substance use disorder clinical trials, and make observations that could inform researchers seeking to implement effectiveness research in SUD treatment settings. This is relevant because researchers, insurers and public agencies are increasingly asking counselors and treatment organizations to mount complicated evidence-based practices, resulting in multiple sources of performance pressure and competing priorities. Effectiveness research is an indispensable step in moving an innovation into practice, yet counselor attrition is a significant factor in intervention delivery that must be recognized. It is incumbent upon researchers to understand and articulate the challenges in integrating behavioral research into daily provision of care and apply those lessons productively going forward. We believe that this manuscript is relevant to the audience of addiction service delivery and research, and to the journal’s focus on implementation science and clinical research in the addiction treatment context.“

The Authors’ Own Words: Gender-Specific Predictors of Methadone Treatment Outcomes Among African Americans at an Urban Clinic

Nov 17, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Gender-Specific Predictors of Methadone Treatment Outcomes Among African Americans at an Urban Clinic

Jamey J. Lister, PhD; Suzanne Brown, PhD; Mark K. Greenwald, PhD; & David M. Ledgerwood , PhD

Substance Abuse Vol. 40, Iss. 2, 2019

“This study delivers the first gender-specific methadone treatment implications among African Americans or any racial minority group, intent on addressing minority health disparities. We identified gender differences and differential MMT outcome predictors between African American female and male patients. We recommend interdisciplinary stakeholders across clinical and research fields consider these findings as they develop and implement assessment and treatment protocols tailored to African American patient needs.“

The Authors’ Own Words: ‘A Scarlet Letter:’ Stigma and Other Factors Affecting Trust in the Healthcare System for Women Seeking Substance Abuse Treatment in a Community Setting

Nov 16, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

‘A Scarlet Letter:’ Stigma and Other Factors Affecting Trust in the Healthcare System for Women Seeking Substance Abuse Treatment in a Community Setting

Joshua D. Cockroft, BA; Susie M. Adams, PhD, RN, PMHNP; Kemberlee Bonnet, MA; Deondria Matlock, MS; Jessica McMillan, DNP, RN, PMHNP; & David Schlundt , PhD

Substance Abuse Vol. 40, Iss. 2, 2019

“Though derived from a small sample size, the findings of this study demonstrate multiple factors that influence trust of the healthcare system for women who seek substance abuse treatment in a community setting. Efforts should be made to address components of healthcare organizations that predispose to stigma, poor quality of care, negatively aligned payment structure and reimbursement, ensuring patients’ rights and protections, and mediating the healthcare system’s potential role in causing or influencing an individual’s substance use disorder (SUD). These findings suggest that public health or institutional interventions to improve treatment for women with a history of SUD may require direct engagement with experiential and structural factors that influence trust and healthcare entry and engagement in order to be effective.“